Published in Cancer Weekly, April 24th, 2007
"ISF caused a dose-dependent decrease in viability (p <0.05) and DNA synthesis (p...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-04-24)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.